Opinion

Video

Overview of Novel Treatments for Retinal Vascular Diseases

A panelist discusses novel treatments for retinal vascular diseases, including faricimab, aflibercept, and port delivery system with ranibizumab.

Video content above is prompted by the following:
Could you briefly provide an overview of the new treatments available for retinal vascular diseases?

  1. Faricimab
  2. Aflibercept 8mg
  3. port delivery system with ranibizumab

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(mage credit: Ophthalmology Times) S. Robert Levine, MD, on the DRD Cure Accelerator: A global moonshot for retinal disease
(Image credit: Ophthalmology Times) CCOI sets the stage for global ophthalmic innovation at Stanford Summit on July 23
(Image credit: Ophthalmology Times) Accelerating eye health innovation through CCOI – Stanford Summit
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game (Part 2)
(Image credit: Ophthalmology Times) 50 years of ophthalmology: What changed the game? (Part 1)
(Image credit: Ophthalmology Times) From MIGS to gene therapy: Inder Paul Singh, MD, celebrates the past and future of glaucoma care
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
Related Content
(Image credit: Wills Eye Hospital) Wills Eye Hospital names Julia A. Haller, MD, as new chief executive officer
August 2nd 2025

Wills Eye Hospital names Julia A. Haller, MD, as new chief executive officer

3 Things You Should Know About the GA Pipeline
August 2nd 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

(Image credit: AdobeStock/iQoncept) Q&A: Jeffrey L. Goldberg, MD, PhD, on the rise of clinical trials centers of excellence
August 2nd 2025

Q&A: Jeffrey L. Goldberg, MD, PhD, on the rise of clinical trials centers of excellence

Patient-Centered Treatment Strategies in the Management of nAMD and DME
August 2nd 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

(Image credit: AdobeStock/Vitalii Vodolazskyi) Yale researchers identify corneal ulcer pathogens by testing tears
August 2nd 2025

Yale researchers identify corneal ulcer pathogens by testing tears

(Image credit: Wilmer Eye Institute/Johns Hopkins Medicine)
August 2nd 2025

Wilmer Eye Institute marks 100 years: honoring the past, shaping the future

© 2025 MJH Life Sciences

All rights reserved.